Saxagliptin, alogliptin, and cardiovascular outcomes
- PMID: 24476445
- DOI: 10.1056/NEJMc1313880
Saxagliptin, alogliptin, and cardiovascular outcomes
Comment in
-
Saxagliptin, alogliptin, and cardiovascular outcomes.N Engl J Med. 2014 Jan 30;370(5):483-4. doi: 10.1056/NEJMc1313880. N Engl J Med. 2014. PMID: 24476444 No abstract available.
-
Saxagliptin, alogliptin, and cardiovascular outcomes.N Engl J Med. 2014 Jan 30;370(5):484. doi: 10.1056/NEJMc1313880. N Engl J Med. 2014. PMID: 24482824 No abstract available.
Comment on
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Clinical Trial.
-
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992602 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical